1. Two-site evaluation of the Roche Elecsys Vitamin D total III assay.
- Author
-
Favresse, Julien, Schiettecatte, Johan, Wolff, Fleur, Cotton, Frederic, Elsen, Marc, Eucher, Christine, Rosseels, Catherine, and Anckaert, Ellen
- Subjects
CHOLECALCIFEROL ,LIQUID chromatography-mass spectrometry ,CHEMILUMINESCENCE immunoassay ,MATRIX effect ,VITAMIN D - Abstract
The high request for vitamin D testing in the last decades has led manufacturers to develop assays on automated immunoassay platforms. The objective of this study was to evaluate the performance of the new Elecsys Vitamin D total III assay for the measurement of total 25(OH)D. A total of 844 serum samples collected in two clinical laboratories were used to evaluate the new Roche Elecsys Vitamin D total III assay. Comparisons with Roche Elecsys Vitamin D total II and liquid chromatography tandem mass spectrometry (LC-MS/MS) were carried out. Additionally, assay imprecision, linearity, matrix effects, biotin interference, cross-reactivity with 24,25(OH)
2 D3 and 3-epi-25(OH)D3 , and outlier rate were evaluated for the Elecsys Vitamin D total III assay. Only the comparison between LC-MS/MS and Roche Elecsys Vitamin D total III achieved the optimal specification for bias (i.e., <3.4%). Imprecision, linearity and matrix effects showed acceptable results. The biotin interference threshold was increased up to 1,200 ng/mL and the outlier rate was low (0.26%). The cross-reactivity with 24,25(OH)2 D3 and 3-epi-25(OH)D3 was weak or modest in available patient samples. However, using SRM972a with a high level of 3-epi-25(OH)D3 (enriched) revealed an important cross-reactivity with both Roche Elecsys Vitamin D total II and III assays (+74.7% and +73.7%). In conclusion, the Roche Elecsys Vitamin D total III assay presents several advantages compared to the previous assay generation: higher biotin interference threshold, broader measuring range, and better comparability with LC-MS/MS. However, the cross-reactivity toward 3-epi-25(OH)D3 is still problematic in high titer samples. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF